Cole Ikkala active positions
| Companies | Position | Start | End |
|---|---|---|---|
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 30/06/2020 | - |
Career history of Cole Ikkala
Former positions of Cole Ikkala
| Companies | Position | Start | End |
|---|---|---|---|
| NVN LIQUIDATION, INC. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - |
Statistics
International
| United States | 3 |
Operational
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NVN LIQUIDATION, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Cole Ikkala
- Experience
